References: Therapeutic Guidelines
Genevieve Adamo MPS (Image: Steve Christo Photography)[/caption]
Supplying medication to a third party
Key considerations and a recommended course of action when a pharmacist is asked to supply medication to a third party.
Scenario:
A 20-year-old man approaches a...
Changes to injectable weight loss medicines
The landscape for glucagon-like peptide-1 receptor agonists (GLP-1RAs) used for weight loss is changing in Australia as demand continues to grow.
Helping patients understand new vaping restrictions
With additional vaping restrictions rolling out throughout 2024, more patients will likely seek therapeutic vaping products.
How to identify the most accurate RATs
Find out which COVID-19 rapid antigen tests are the best-performing, and what product has failed to detect the virus.
Intranasal vaccine stops infection at the source
Administered to the nasal mucosa, a spike-based formulation triggers rapid local defences that clear the COVID-19 virus where it enters.
In 2022, a year after...
TGA issues two new safety alerts for GLP-1 RA products
The Therapeutic Goods Administration (TGA) has today (Monday 1 December) made updates to product warnings for GLP-1 and dual GIP/GLP-1 receptor agonists for two...
